[(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines

[(1H-indazol-3-yl)methyl]phenols and...

[(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]e

[(4-heteroaryl-1-piperazinyl)alkoxy]-3,4-dihydro-1(2h)-naphthale

[(4-heteroaryl-1-piperindyl)alkoxy]-3,4-dihydro-1(2H)-naphthalen

[(4-phenyl-1,3-dioxan-cis-5-yl)alkyl]phenylalkanoic acid derivat

[(5-oxo)-2-pyrrolidinyl)methyl]cyclohexaneacetamides, compositio

[(alkoxy)pyridinyl]amine compounds which are useful in the treat

[(Arylalkylpiperidin-4-yl)methyl]-2a,3,4,5-tetrahydro- 1(2H)-ace

[(Benzodioxan, benzofuran or benzopyran) alkylamino] alkyl subst

[(Benzodioxan, benzofuran or benzopyran) alkylamino] alkyl subst

[(Hydroxyphenylamino) carbonyl] pyrroles

[(Imidazol-4(and 5)-yl)methyl] tetracyclic ketones having 5-HT.s

[(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyal

[1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists

[1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists

[1,3]-Dioxolo[4,5-f]benzimidazoles and [1,4]-dioxino[2,3-f]benzi

[1,4]Diazocino[7,8,1-hi]indole derivatives as antipsychotic...

[2(4,5-diaryl-2 oxazoyl substituted phenoxy alkanoic acid and es

[2-[(Nitropyridinyl)amino]phenyl]arylmethanones in a process for